Taiwan FDA registration 65ee1e05206f95eec7932a91af3b1ad3
"DXN" creatinine test reagent
TW: “德信”肌酸酐檢驗試劑
Taiwan·Risk Class 2·DIASYS DIAGNOSTIC SYSTEMS GMBH·Registered Oct 16, 2017 – Oct 16, 2027ActiveRegistration details
- Analysis ID
- 65ee1e05206f95eec7932a91af3b1ad3
- Customs Code
- DHA05603007502
Company information
- Manufacturer
- DIASYS DIAGNOSTIC SYSTEMS GMBH
- Manufacturer Country
- Germany
- Authorized Representative
- TUNYEN ENTERPRISE CORPORATION
Product details
- Intended Use
- This product is used with optical colorimetric analysis instruments to quantitatively detect creatinine concentration in serum, plasma or urine.
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A.1150 校正品;; A.1225 肌氨酸酐試驗系統(Creatininetestsystem)
- Import Information
- import
Dates and status
- Registration Date
- Oct 16, 2017
- Expiry Date
- Oct 16, 2027
About this record
Access comprehensive regulatory information for "DXN" creatinine test reagent in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 65ee1e05206f95eec7932a91af3b1ad3 and manufactured by DIASYS DIAGNOSTIC SYSTEMS GMBH. The authorized representative in Taiwan is TUNYEN ENTERPRISE CORPORATION.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices